153 related articles for article (PubMed ID: 36877496)
1. Alzheimer Disease Blood Biomarkers in Patients With Out-of-Hospital Cardiac Arrest.
Ashton NJ; Moseby-Knappe M; Benedet AL; Grötschel L; Lantero-Rodriguez J; Karikari TK; Hassager C; Wise MP; Stammet P; Kjaergaard J; Friberg H; Nielsen N; Cronberg T; Zetterberg H; Blennow K
JAMA Neurol; 2023 Apr; 80(4):388-396. PubMed ID: 36877496
[TBL] [Abstract][Full Text] [Related]
2. Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest.
Moseby-Knappe M; Mattsson N; Nielsen N; Zetterberg H; Blennow K; Dankiewicz J; Dragancea I; Friberg H; Lilja G; Insel PS; Rylander C; Westhall E; Kjaergaard J; Wise MP; Hassager C; Kuiper MA; Stammet P; Wanscher MCJ; Wetterslev J; Erlinge D; Horn J; Pellis T; Cronberg T
JAMA Neurol; 2019 Jan; 76(1):64-71. PubMed ID: 30383090
[TBL] [Abstract][Full Text] [Related]
3. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid biomarkers in cardiac arrest survivors.
Rosén C; Rosén H; Andreasson U; Bremell D; Bremler R; Hagberg L; Rosengren L; Blennow K; Zetterberg H
Resuscitation; 2014 Feb; 85(2):227-32. PubMed ID: 24231570
[TBL] [Abstract][Full Text] [Related]
5. Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status.
Palmqvist S; Janelidze S; Stomrud E; Zetterberg H; Karl J; Zink K; Bittner T; Mattsson N; Eichenlaub U; Blennow K; Hansson O
JAMA Neurol; 2019 Sep; 76(9):1060-1069. PubMed ID: 31233127
[TBL] [Abstract][Full Text] [Related]
6. Plasma Biomarkers of Alzheimer Disease in Women With and Without HIV.
Li X; Yucel R; Clervius H; Kamalakar K; Zetterberg H; Blennow K; Zhang J; Adimora A; Collins LF; Fischl M; Kassaye S; Maki P; Seaberg E; Sharma A; Vance D; Gustafson DR
JAMA Netw Open; 2023 Nov; 6(11):e2344194. PubMed ID: 38019518
[TBL] [Abstract][Full Text] [Related]
7. Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers.
Janelidze S; Christian BT; Price J; Laymon C; Schupf N; Klunk WE; Lott I; Silverman W; Rosas HD; Zaman S; Mapstone M; Lai F; Ances BM; Handen BL; Hansson O
JAMA Neurol; 2022 Aug; 79(8):797-807. PubMed ID: 35789365
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
Sutphen CL; Jasielec MS; Shah AR; Macy EM; Xiong C; Vlassenko AG; Benzinger TL; Stoops EE; Vanderstichele HM; Brix B; Darby HD; Vandijck ML; Ladenson JH; Morris JC; Holtzman DM; Fagan AM
JAMA Neurol; 2015 Sep; 72(9):1029-42. PubMed ID: 26147946
[TBL] [Abstract][Full Text] [Related]
9. Blood biomarkers in mild cognitive impairment patients: Relationship between analytes and progression to Alzheimer disease dementia.
Silva-Spínola A; Lima M; Leitão MJ; Bernardes C; Durães J; Duro D; Tábuas-Pereira M; Santana I; Baldeiras I
Eur J Neurol; 2023 Jun; 30(6):1565-1573. PubMed ID: 36880887
[TBL] [Abstract][Full Text] [Related]
10. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
[TBL] [Abstract][Full Text] [Related]
11. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A
Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624
[TBL] [Abstract][Full Text] [Related]
12. Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients.
Huang Y; Li Y; Xie F; Guo Q
CNS Neurosci Ther; 2022 Dec; 28(12):2195-2205. PubMed ID: 36074638
[TBL] [Abstract][Full Text] [Related]
13. Association of Blood-Based Brain Injury Biomarker Concentrations With Outcomes After Pediatric Cardiac Arrest.
Fink EL; Kochanek PM; Panigrahy A; Beers SR; Berger RP; Bayir H; Pineda J; Newth C; Topjian AA; Press CA; Maddux AB; Willyerd F; Hunt EA; Siems A; Chung MG; Smith L; Wenger J; Doughty L; Diddle JW; Patregnani J; Piantino J; Walson KH; Balakrishnan B; Meyer MT; Friess S; Maloney D; Rubin P; Haller TL; Treble-Barna A; Wang C; Clark RRSB; Fabio A;
JAMA Netw Open; 2022 Sep; 5(9):e2230518. PubMed ID: 36074465
[TBL] [Abstract][Full Text] [Related]
14. Neurologic Prognostication After Cardiac Arrest Using Brain Biomarkers: A Systematic Review and Meta-analysis.
Hoiland RL; Rikhraj KJK; Thiara S; Fordyce C; Kramer AH; Skrifvars MB; Wellington CL; Griesdale DE; Fergusson NA; Sekhon MS
JAMA Neurol; 2022 Apr; 79(4):390-398. PubMed ID: 35226054
[TBL] [Abstract][Full Text] [Related]
15. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
[TBL] [Abstract][Full Text] [Related]
16. Serum Markers of Neurodegeneration Are Strongly Linked to Heart Failure Severity and Outcome.
Wurm R; Prausmüller S; Ponleitner M; Spinka G; Weidenhammer A; Arfsten H; Heitzinger G; Panagiotides NG; Strunk G; Bartko P; Goliasch G; Stögmann E; Hengstenberg C; Hülsmann M; Pavo N
JACC Heart Fail; 2024 Jun; 12(6):1073-1085. PubMed ID: 38839151
[TBL] [Abstract][Full Text] [Related]
17. Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer's Disease.
Shi Y; Lu X; Zhang L; Shu H; Gu L; Wang Z; Gao L; Zhu J; Zhang H; Zhou D; Zhang Z
ACS Chem Neurosci; 2019 Aug; 10(8):3479-3485. PubMed ID: 31145586
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
[TBL] [Abstract][Full Text] [Related]
19. Association of Circulating MicroRNA-124-3p Levels With Outcomes After Out-of-Hospital Cardiac Arrest: A Substudy of a Randomized Clinical Trial.
Devaux Y; Dankiewicz J; Salgado-Somoza A; Stammet P; Collignon O; Gilje P; Gidlöf O; Zhang L; Vausort M; Hassager C; Wise MP; Kuiper M; Friberg H; Cronberg T; Erlinge D; Nielsen N;
JAMA Cardiol; 2016 Jun; 1(3):305-13. PubMed ID: 27438111
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]